1. Home
  2. INAB vs FENG Comparison

INAB vs FENG Comparison

Compare INAB & FENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IN8bio Inc.

INAB

IN8bio Inc.

HOLD

Current Price

$1.47

Market Cap

22.9M

Sector

Health Care

ML Signal

HOLD

Logo Phoenix New Media Limited

FENG

Phoenix New Media Limited

HOLD

Current Price

$1.88

Market Cap

20.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
INAB
FENG
Founded
2016
1998
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
22.9M
20.9M
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
INAB
FENG
Price
$1.47
$1.88
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
58.7K
8.8K
Earning Date
03-12-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$1.28
52 Week High
$4.20
$3.65

Technical Indicators

Market Signals
Indicator
INAB
FENG
Relative Strength Index (RSI) 39.15 60.47
Support Level $1.17 $1.72
Resistance Level $2.14 $2.03
Average True Range (ATR) 0.20 0.05
MACD -0.03 0.01
Stochastic Oscillator 5.30 69.57

Price Performance

Historical Comparison
INAB
FENG

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About FENG Phoenix New Media Limited

Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.

Share on Social Networks: